Long-Acting Injectable Antipsychotic To Prevent Relapse in First Episode Schizophrenia
Research published in JAMA Psychiatry demonstrated that long-acting, injectable, second-generation antipsychotic medication has tremendous potential to bring clinical stability to persons with first-episode schizophrenia. According to the authors, “long-acting medications are rarely used following a first episode of schizophrenia.” Patients with recent onset of schizophrenia (n=86) were randomized to receive long-acting injectable risperidone or oral […]
Read MoreThe Myth of Schizophrenia as a Progressive Brain Disease
Schizophrenia has historically been considered to be a deteriorating disease, a view reinforced by recent MRI findings of progressive brain tissue loss over the early years of illness. Zipursky and colleagues challenge this concept. Schizophrenia Bulletin [More…]
Read MoreEarly Detection of Schizophrenia: The Time Is Now
In an editorial in Psychiatric News by APA President Jeffrey Lieberman, MD, he describes that “we are at another game-changing moment in psychiatry with the rise of the early detection and intervention strategy (EDIS). This new therapeutic strategy and model of care could have a significant effect on our ability to treat and limit the […]
Read MorePain conditions among veterans with schizophrenia or bipolar disorder
A study published in General Hospital Psychiatry evaluated the rates of chronic, noncancer pain conditions in patients diagnosed with schizophrenia or bipolar disorder within the Veterans Health Administration (VHA) System. Researchers used a cross-sectional design that used administrative data extracted from VHA treatment records of all individuals receiving VHA services in one year (N=751). They […]
Read MoreMagnetic Stimulation Can Improve Memory in Schizophrenia
A new study published in Biological Psychiatry provides new evidence that stimulating the brain using repetitive transcranial magnetic stimulation (rTMS) may be an effective strategy to improve cognitive function. A randomized, 4-week controlled trial (n=27) evaluated whether rTMS can improve working memory in schizophrenia. Patients performed the verbal working memory n-back task before and after […]
Read More